Gyre Therapeutics Inc. (GYRE)
NASDAQ · Healthcare
Gyre Therapeutics Inc. Long Term Debt 2021–2025
Gyre Therapeutics Inc. annual long term debt history from 2021 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.
- Gyre Therapeutics Inc. long term debt as of December 31, 2025: 303,000, a 65.76% decrease year-over-year.
- Gyre Therapeutics Inc. long term debt for 2025 were 303,000, a 65.76% decrease from 2024.
- Gyre Therapeutics Inc. long term debt for 2024 were 885,000, a 344.72% increase from 2023.
- Gyre Therapeutics Inc. long term debt for 2023 were 199,000, a 1097.93% increase from 2022.
- Gyre Therapeutics Inc. long term debt for 2022 were 16,612.
Long Term Debt
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Gyre Therapeutics Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2025 | $0 |
| 2024 | $1 |
| 2023 | $0 |
| 2022 | $0 |
| 2021 | $0 |
Gyre Therapeutics Inc. Long Term Debt — FAQ
Gyre Therapeutics Inc. (GYRE) long term debt over the last 5 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see GYRE's long term debt history?
The chart and table above show Gyre Therapeutics Inc.'s long term debt by year and by quarter, including the growth rate.